Jun 18, 2018
On Tuesday, July 3, Penn State Health Milton S. Hershey Medical Center and the Hershey Symphony Orchestra will present “An American Salute,” the annual Independence Day celebration on the front lawn of the Medical Center.
Jun 14, 2018
A biomimetic nanosystem can deliver therapeutic proteins to selectively target cancerous tumors, according to a team of Penn State researchers.
Jun 6, 2018
Natasha Renee Burse, a graduate research assistant and doctor of public health (DrPH) student at Penn State College of Medicine, is working to improve outcomes for minority women diagnosed with cancer.
Jun 4, 2018
This past weekend, Penn State Health launched a new, integrated electronic health record and patient billing system—called CareConnect.
May 23, 2018
Penn State Health and Andrews Patel Hematology/Oncology announced today they have reached agreement to join together to provide unmatched, patient-focused oncology and hematology services to central Pennsylvania and the surrounding region.
May 14, 2018
Mutations in genes that help repair damage to DNA may aid in predicting the prognosis of patients with bladder and other related cancers, according to researchers.
May 10, 2018
A team of medical researchers have taken a step in investigating whether a type of RNA found to be linked to cancers - called microRNAs - could one day be used as a more accurate screening test for prostate cancer.
May 7, 2018
Penn State Health is moving forward with significant construction and renovation projects that will allow the health system to better meet the health care needs of the community and create greater opportunities to advance biomedical and health science research and education.
Apr 16, 2018
The Penn State Cancer Institute and broader Penn State community are mourning the passing of alumnus and longtime cancer research philanthropist Warren Gittlen.
Apr 13, 2018
A lot of people seem to put stock in the “stage” of cancer with which they or their loved one has been diagnosed. We learn more about the stages of cancer from Dr. Joseph Drabick, chief of hematology and oncology at Penn State Cancer Institute.
